Ractigen
Suzhou, CN · Founded 2017 · 21 employees on LinkedIn · 2 known investors
Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.
Founders & leadership
Ractigen was founded in 2017 by Dr. Long-Cheng Li.
DL
Dr. Long-Cheng LiCEO and Founder
DM
Dr. Moorim KangChief Technology Officer
Investors · 2
Frequently asked questions
- What does Ractigen do?
- Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.
- Who founded Ractigen?
- Ractigen was founded by Dr. Long-Cheng Li in 2017.
- Who are Ractigen's investors?
- Ractigen's investors include SDIC Venture Capital, Eisai Innovation, Inc..
- Where is Ractigen headquartered?
- Ractigen is headquartered in Suzhou, CN.